Lang James Paul
Halozyme Therapeutics, Inc. · Director
Lang James Paul is listed in public filings as director. This Lang James Paul insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO), BioVie Inc. (BIVI), and OptimizeRx Corporation (OPRX). Investors use Lang James Paul's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $398k6k shares | Grant / ExerciseMay 5, 2026 | $397.9K6k shares | $65.87 | -- | |
| --4.7k shares | Grant / ExerciseMay 5, 2026 | Disclosure amount unavailable3.8k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $433k330.5k shares | Grant / ExerciseJan 5, 2026 | $433.0K330.5k shares | $1.31 | -- | |
| $118k90k shares | Grant / ExerciseJan 5, 2026 | $117.9K90k shares | $1.31 | -- | |
| --889 shares | Grant / ExerciseJan 2, 2026 | Disclosure amount unavailable889 shares | -- | -- | |
| $94k1.3k shares | Grant / ExerciseJan 2, 2026 | $94.4K1.3k shares | $70.31 | -- | |
| --399.3k shares | Grant / ExerciseJun 11, 2025 | Disclosure amount unavailable9.9k shares | -- | -- | |
| $3.0M389.5k shares | BuyMar 14, 2025 | $2.4M321.4k shares | $7.60 | -- | |
| $43k22.7k shares | Grant / ExerciseDec 20, 2024 | $43.1K22.7k shares | $1.90 | -- | |
| $207k61.6k shares | Grant / ExerciseNov 20, 2024 | $207.0K61.6k shares | $3.36 | -- |